Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: BDR who wrote (6680)	5/12/1999 9:30:00 AM
From: Linda Kaplan	Read Replies (2) \| Respond to of 7041

Some random thoughts: The longs should be thanking the shorts for the current price of the stock. I think if it weren't for the shorts, who've been taking profits by buying stock, the price of this stock would be much lower. I do think that any long who is recommending buying here is probably planning to sell into any rally. The shorts have been saying that the trials on this drug were weak and the non-approvable letter is proof of that. If SGP could have gotten the drug approved they would have continued with the hearing. Whether there will ever be another application remains to be seen, but it's very unlikely there'll ever be approval, IMO. With all the other great stocks to play, who would want to have dead money in ZONA for a year, betting on a very bad bet that it will get FDA approval for Vasomax? It just doesn't make sense to me. There were a lot of longs who were active on this thread and were promising that the stock would be very high. That "tick tock" concept is based on that premise: that the stock is going to the moon. Well,I notice that none of them has shown up with the good grace to admit they were wrong! Linda